PHH News & Events

Park Ha Biological Technology (BYAH) announced significant progress in its global expansion by initiating cooperation with Amazon (AMZN) North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory efforts are being executed efficiently and systematically, with overall progress advancing ahead of schedule. This signifies that Park Ha Biological's online commercialization strategy in North America has entered a substantive implementation phase, laying a solid foundation for the launch of its flagship stores and sustained overseas operations. Four key workstreams are currently advancing in parallel: store qualification registration, Amazon brand registration enrollment, establishment of a compliance framework for the North American market, and the development of localized product operation strategies. These efforts are being executed efficiently and systematically, with overall progress steadily exceeding expectations. This disciplined approach positions Park Ha Biological to successfully launch its flagship storefront on Amazon's North American marketplace and sustain long-term international operations.

Park HA Biological Tech files $300M mixed securities shelf

Park Ha Biological Technology announced the pricing of a best-efforts follow-on public offering of 21,875,000 units at an offering price of $0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value $0.00002 per share and one warrant to purchase one Class A Ordinary Share. Each Warrant will have an exercise price of $0.112 per Class A Ordinary Share and will be exercisable beginning on the issuance date and ending on the one-year anniversary of the issuance date. The Company expects to receive aggregate gross proceeds of $2.45M from the offering, before deducting placement agent commissions and other estimated expenses payable by the Company, excluding the exercise of any Warrant offered. The offering is expected to close on or about January 28, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from this offering for the expansion of directly operated stores in China, and the specific allocation of net proceeds to each market will be based on market conditions. D. Boral Capital is acting as the Sole Placement Agent for the offering.

Park Ha Biological Technology announced that the Company will be changing its ticker symbol from "PHH" to "BYAH". Effective on Tuesday October 28, 2025, the Company's ordinary shares will trade on Nasdaq under the new symbol "BYAH". "To prevent potential confusion with a delisted company that used the same symbol, we will officially change the ticker symbol," CEO of the Company, Xiaoqiu Zhang commented. The change of the Company's ticker symbol to 'BYAH' will have a positive impact on building the Company's long-term brand influence and enhancing our brand value."